Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions

British Journal of Cancer

Volumn 85, Issue 1, 2001, Pages 115-121

  Finnegan, N M ^a   Curtin, J F ^a   Prevost, G ^b   Morgan, B ^c   Cotter, T G ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b Institut Henri Beaufour   (France)

^c Biomeasure Inc   (United States)

Author keywords

Apoptosis; Bcl 2; BH3; Peptide; Prostate

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BH3 PROTEIN; CASPASE INHIBITOR; PROTEIN; PROTEIN BAK; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL DEATH; CONTROLLED STUDY; DIMERIZATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION;

AMINO ACID CHLOROMETHYL KETONES; AMINO ACID SEQUENCE; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASES; CYSTEINE PROTEINASE INHIBITORS; DIMERIZATION; ELECTROPORATION; HUMANS; MALE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PRECIPITIN TESTS; PROSTATIC NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0035816232     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1850     Document Type: Article

References (28)

1. The Bcl-2 protein family: Arbiters of cell survival
2. Mechanisms controlling cellular suicide: Role of Bcl-2 and caspases
3. Androgens induce resistance to Bcl-2-mediated apoptosis in LNCaP prostate cancer cells
4. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding function
5. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone refractory human prostate cancers
6. A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members
7. Taxol induces Bcl-2 phosphorylation and death in prostate cancer cells
8. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein
9. NH2-terminal BH4 domain of Bcl-2 is functional for heterodimerization with Bax and inhibition of apoptosis
10. Bax directly induces release of cytochrome c from isolated mitochondria
11. L, and mcl-1 expression on prostate cancers
12. Current chemotherapy and future directions in research for the treatment of advanced hormone-refractory prostate cancer
13. The proto-oncogene Bcl-2 and its role in regulating apoptosis
14. bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer
15. Expression of the proto-oncogene Bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer
16. Enzymatic programming of apoptotic cell death
17. Bcl-2 heterodimerizes in-vivo with a conserved homolog, Bax, that accelerates programmed cell death
18. Bik and Bak induce apoptosis downstream of CrmA but upstream of inhibitor of apoptosis
19. The binding properties and biological activities of Bcl-2 and Bax in cells exposed to apoptotic stimuli
20. L, and Apaf-1 form a terniary complex
21. Fas-mediated apoptosis in human prostatic carcinoma cell lines
22. Target to apoptosis: A hopeful weapon for prostate cancer
23. Molecular thanatopsis: A discourse on the Bcl-2 family and cell death
24. L and Bct-2, displaces Bax and promotes cell death
25. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax
26. Proapoptotic protein Bax heterodimenses with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2
27. Growth factors inactivate the cell death promoter BAD by phosphorylation of its BH3 domain on Ser155
28. Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types